These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27672687)

  • 21. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2013 Sep; 62(RR-07):1-43. PubMed ID: 24048214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.
    Grohskopf LA; Sokolow LZ; Fry AM; Walter EB; Jernigan DB
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(22):643-645. PubMed ID: 29879095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACIP releases recommendations for use of live, attenuated influenza vaccine.
    Ressel GW;
    Am Fam Physician; 2003 Dec; 68(11):2275-6. PubMed ID: 14677671
    [No Abstract]   [Full Text] [Related]  

  • 24. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
    Kahn KE; Santibanez TA; Zhai Y; Singleton JA
    Vaccine; 2015 Sep; 33(39):5196-203. PubMed ID: 26238724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All you need to know about flu vaccines this season.
    Can Fam Physician; 2015 Oct; 61(10):880, e457-8. PubMed ID: 26472795
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Merckx J; McCormack D; Quach C
    Vaccine; 2016 Feb; 34(6):750-6. PubMed ID: 26752064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
    Ambrose CS; Wu X; Knuf M; Wutzler P
    Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.
    Fiore AE; Shay DK; Broder K; Iskander JK; Uyeki TM; Mootrey G; Bresee JS; Cox NS; ;
    MMWR Recomm Rep; 2008 Aug; 57(RR-7):1-60. PubMed ID: 18685555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harper SA; Fukuda K; Uyeki TM; Cox NJ; Bridges CB;
    MMWR Recomm Rep; 2004 May; 53(RR-6):1-40. PubMed ID: 15163927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccinations and the 2008-09 flu season: what you need to know.
    Heins JR
    S D Med; 2008 Oct; 61(10):374-5. PubMed ID: 19051756
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccinating high-risk children with the intranasal live-attenuated influenza vaccine: the Quebec experience.
    Quach C
    Paediatr Respir Rev; 2014 Dec; 15(4):340-7. PubMed ID: 25242731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere.
    Pebody R; McMenamin J; Nohynek H
    Arch Dis Child; 2018 Jan; 103(1):101-105. PubMed ID: 28855230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More choices for avoiding the flu this winter.
    Consum Rep; 2003 Nov; 68(11):47. PubMed ID: 14584505
    [No Abstract]   [Full Text] [Related]  

  • 36. Influenza vaccination update.
    Todd B
    Am J Nurs; 2006 Oct; 106(10):30-1. PubMed ID: 17016087
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influenza, risk factor in aged persons? Apropos of a controlled trail of anti-influenza vaccination].
    Reginster M; Thieu QS; Daenen G; Lefin H; Mutsers A
    Rev Med Liege; 1984 Dec; 39(23):854-60. PubMed ID: 6522896
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    ;
    MMWR Recomm Rep; 2009 Aug; 58(RR-10):1-8. PubMed ID: 19713882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.